Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 23 hours ago

Indications

Empagliflozin + Metformin Hydrochloride tablet is used in adults with type 2 diabetes mellitus, alongside diet and exercise. Doctors prescribe it in three situations. The first is when blood sugar isn't controlled well enough on the highest dose of Metformin alone that the patient can tolerate. The second is when a patient is on Metformin plus other medicines for diabetes and still isn't controlled. In that case Empagliflozin + Metformin Hydrochloride is used together with those other medicines. The third is when the patient already takes Empagliflozin and Metformin as separate tablets.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Empagliflozin is an inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2). SGLT2 is the main transporter that takes glucose from the kidney back into the circulation. When Empagliflozin blocks SGLT2, the kidney reabsorbs less of the glucose it has filtered, and the renal threshold for glucose falls. As a result, more glucose leaves the body in the urine.

Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug, used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose, and it does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production and decreases intestinal absorption of glucose. It also improves insulin sensitivity by increasing peripheral glucose uptake and utilization.

Pregnancy & Breastfeeding

Women should be told that Empagliflozin + Metformin Hydrochloride may carry a risk to the baby in the womb, especially in the second and third trimesters. It is not recommended while breastfeeding.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: The dose of this Empagliflozin and Metformin Hydrochloride combination should be set for each patient, based on how well it works and how well it is tolerated. Take it twice daily with meals. Raise the dose gradually, so the gastrointestinal side effects caused by Metformin Hydrochloride are reduced. The maximum recommended daily dose is 2000 mg for Metformin Hydrochloride and 25 mg for Empagliflozin. For the starting dose, the choice depends on what the patient already takes. A patient on Metformin Hydrochloride switches to the combination containing Empagliflozin 5 mg, with a similar total daily dose of Metformin Hydrochloride. A patient on Empagliflozin switches to the combination containing Metformin Hydrochloride 500 mg, with a similar total daily dose of Empagliflozin. A patient already treated with Empagliflozin and Metformin Hydrochloride as separate medicines switches to the combination with the same total daily dose of each. If a patient has volume depletion and hasn't been treated with Empagliflozin before, correct this before starting the combination. For extended-release formulations, the starting dose depends on the patient's current drug regimen. The film coated tablet is taken twice daily with a meal. The extended-release formulation is taken once daily with a meal. In both cases the dose goes up gradually, to reduce the GI adverse effects of Metformin. Adjust the dose according to effectiveness and tolerability, and don't go above the maximum recommended daily dose of Metformin Hydrochloride 2000 mg and Empagliflozin 25 mg. In patients with impaired kidney function, assess renal function before starting the combination. It is contraindicated in patients with an eGFR below 45 mL/min/1.73 m2. For pediatric patients under 18 years of age, safety and effectiveness have not been established.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.